Results 201 to 210 of about 42,805 (221)

Targeting CA125 in cardiovascular disease

International Journal of Cardiology, 2022
Guang-Gui, Zeng, Heng, Li, Chao-Ke, Tang
openaire   +2 more sources

[CA125 in non-Hodgkin's lymphoma].

Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1992
CA125 is an antigenic determinant recognized by monoclonal antibody CA125 raised against a serous ovarian cancer cell line. Elevation of this antigen has been reported in over 80% of women with epithelial ovarian cancer and many other diseases including both malignant and non-malignant ones.
C J, Liu, C H, Tzeng, J H, Liu, S C, Chaou, J M, Liu, S, Fan, R K, Hsieh, S M, Liu, C M, Tiu, R S, Liu   +9 more
openaire   +1 more source

CA125 (Ag)

EMC - Biologie médicale, 2007
openaire   +1 more source

CA125 and malignant lymphomas.

Journal of Clinical Oncology, 1991
C, Sebban, Y, Lasne, V, Berenguer, E, Archimbaud, Y, Devaux, J J, Viala   +5 more
openaire   +2 more sources

CA125 in Endometrial Cancer

International Journal of Gynecological Cancer, 2003
G. Colafiglio, A. Cazzolla, G. Di Vagno, G. Cormio, A.M. Caringella, A.R. Di Gilio, L. Selvaggi   +6 more
openaire   +1 more source

CA125

2016
openaire   +1 more source

[CA125].

Nihon rinsho. Japanese journal of clinical medicine, 2005
Kazuo, Kuzuya, Masaki, Kuwabara, Yutaka, Ariyoshi   +2 more
openaire   +1 more source

CA125

2008
openaire   +1 more source

[CA125].

Nihon rinsho. Japanese journal of clinical medicine, 2000
Y, Ariyoshi, M, Kuwabara, K, Kuzuya
openaire   +1 more source

CA125

2011
openaire   +1 more source